Akèy › Kansè Uretè
Etid klinik pou Kansè Uretè ap rekrite nan Etazini
8 etid pou Kansè Uretè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
- Colorado3 etid
- Florid3 etid
- Georgia3 etid
- Illinois3 etid
- Indiana3 etid
- Kalifòni3 etid
- Massachusetts3 etid
- Michigan3 etid
- Minnesota4 etid
- Missouri3 etid
- New York3 etid
- North Carolina3 etid
- Ohio4 etid
- Texas3 etid
- Utah3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06764095Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07667335ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT05756569Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT07087860Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.